3D Kinematic Assessment of the Human Knee During Physical and Daily Life Activities
Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Aug 6, 2012
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the movement of the knee in three dimensions (3D) during different activities, like walking or running. The goal is to develop a new system that accurately measures how the knee moves, especially in people who have knee problems. By understanding these movements better, doctors hope to improve treatments for knee injuries. The trial will use a special imaging technique and a device that can be placed in the knee with just a local anesthetic, meaning patients won't need to go under general anesthesia.
To participate in this trial, you should be someone who is scheduled to have knee surgery for a specific issue called a medial meniscal tear. You will not be eligible if you have an active infection, severe swelling, or other specific knee problems that could affect your ability to participate. If you join, you can expect to undergo some tests to measure how your knee moves during various activities, and your results may help improve understanding and treatment options for knee injuries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients awaiting knee arthroscopy under local anesthesia for a medial meniscal tear
- Exclusion Criteria:
- • Active infection
- • Severe swelling of the knee
- • Knee flexion contracture
- • Knee flexion less than 120 degrees
- • Gross limping
- • Inability to perform the various motor tasks required by the study protocol
About Centre Hospitalier De L'université De Montréal (Chum)
The Centre Hospitalier de l'Université de Montréal (CHUM) is a leading academic health institution in Canada, dedicated to advancing patient care through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUM is committed to leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. Collaborating with a network of healthcare professionals and researchers, CHUM fosters a rigorous research environment that prioritizes patient safety, ethical standards, and scientific integrity, positioning itself at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montréal, Quebec, Canada
Patients applied
Trial Officials
Frédéric Lavoie, MD MSc FRCSC
Principal Investigator
CHUM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials